Who has invested in Metsera?

Pfizer are named among the investors backing Metsera.

Metsera Funding: $10B Raised, IPO (2024)

Metsera funding overview

Metsera is a Biotech company based in New York City. Metsera has raised $10B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in June 2024. The round record for Metsera runs through 2024; nothing later has been disclosed. Investors on record include Pfizer.

Metsera at a glance

Total raised: $10B
Latest round: IPO
Latest round date: June 2024
Industry: Biotech
Headquarters: New York City
Notable investors: Pfizer

Frequently asked about Metsera funding

How much has Metsera raised?: Metsera has raised $10B in total disclosed funding across the rounds on record.
Who has invested in Metsera?: Pfizer are named among the investors backing Metsera.
What was the latest Metsera funding round?: The most recent disclosed round is an IPO, announced in June 2024.
Where is Metsera based?: Metsera is based in New York City.
What sector does Metsera operate in?: Metsera is tracked under Biotech from New York City, with $10B in disclosed funding.
When did Metsera last raise?: The last disclosed Metsera round closed in June 2024 at IPO.

Round data for Metsera is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in New York City and backer lists below.

Metsera Funding: $10B Raised, IPO (2024)

Metsera funding overview

Metsera at a glance

Frequently asked about Metsera funding

Metsera founders (1)

Companies related to Metsera (40)

Browse related funding lists (4)